Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety

[1]  Farshid Zargari,et al.  Study of tyramine-binding mechanism and insecticidal activity of oil extracted from Eucalyptus against Sitophilus oryzae , 2022, Frontiers in Chemistry.

[2]  H. Abdel‐Aziz,et al.  Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity , 2022, Scientific Reports.

[3]  T. Laitinen,et al.  Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform , 2022, Scientific Reports.

[4]  B. Song,et al.  Synthesis, Anti-Tomato Spotted Wilt Virus Activities, and Interaction Mechanisms of Novel Dithioacetal Derivatives Containing a 4(3H)-Quinazolinone Pyrimidine Ring. , 2021, Journal of agricultural and food chemistry.

[5]  Razieh Sabet,et al.  Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies , 2021, Research in pharmaceutical sciences.

[6]  R. Sheervalilou,et al.  8-Alkylmercaptocaffeine derivatives: antioxidant, molecular docking, and in-vitro cytotoxicity studies. , 2021, Bioorganic chemistry.

[7]  Robert C. Sinclair,et al.  Uncertainty quantification in classical molecular dynamics , 2020, Philosophical Transactions of the Royal Society A.

[8]  A. Foroumadi,et al.  A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. , 2020, Bioorganic chemistry.

[9]  S. Chander,et al.  Synthesis, biological evaluation and molecular docking of pyrimidine and quinazoline derivatives of 1,5-benzodiazepine as potential anticancer agents , 2020 .

[10]  Zhi Xu,et al.  1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. , 2019, European journal of medicinal chemistry.

[11]  Keunchil Park,et al.  Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial. , 2019, Lung cancer.

[12]  Yusra Sajid Kiani,et al.  Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors , 2019, International journal of molecular sciences.

[13]  K. Zomorodian,et al.  Synthesis of some novel dibromo-2-arylquinazolinone derivatives as cytotoxic agents , 2019, Research in pharmaceutical sciences.

[14]  Bernhard Knapp,et al.  Avoiding False Positive Conclusions in Molecular Simulation: The Importance of Replicas. , 2018, Journal of chemical theory and computation.

[15]  P. V. Van Schil,et al.  Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Ali Ramazani and Zahra Hosseinzadeh.  Anti-cancer Nitrogen-Containing Heterocyclic Compounds , 2018, Current Organic Chemistry.

[17]  J. Gauss,et al.  Accuracy of Rotational Parameters Predicted by High-Level Quantum-Chemical Calculations: Case Study of Sulfur-Containing Molecules of Astrochemical Interest. , 2018, Journal of chemical theory and computation.

[18]  K. Zomorodian,et al.  Synthesis of some quinazolinone derivatives using magnetic nanoparticles-supported tungstic acid as antimicrobial agents , 2018, Journal of the Iranian Chemical Society.

[19]  A. Hameed,et al.  Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016) , 2018, Expert opinion on therapeutic patents.

[20]  J. Menéndez,et al.  Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues. , 2017, European journal of medicinal chemistry.

[21]  Cheng Lu,et al.  Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives. , 2017, Fitoterapia.

[22]  Zahra Ramezani,et al.  A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK1R antagonists/serotonin transporter (SERT) inhibitors , 2017, Comput. Biol. Chem..

[23]  Peter V Coveney,et al.  Rapid, Accurate, Precise, and Reliable Relative Free Energy Prediction Using Ensemble Based Thermodynamic Integration. , 2017, Journal of chemical theory and computation.

[24]  Peter V Coveney,et al.  Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study , 2016, Journal of chemical theory and computation.

[25]  D. A. E. Ella,et al.  Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents , 2016 .

[26]  Sarah L. Greig,et al.  Osimertinib: First Global Approval , 2016, Drugs.

[27]  Charlotte M. Deane,et al.  Rapid, Precise, and Reproducible Prediction of Peptide-MHC Binding Affinities from Molecular Dynamics That Correlate Well with Experiment. , 2015, Journal of chemical theory and computation.

[28]  Rodrigo C. Barros,et al.  Clustering Molecular Dynamics Trajectories for Optimizing Docking Experiments , 2015, Comput. Intell. Neurosci..

[29]  Z. Binkhathlan,et al.  P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. , 2013, Current cancer drug targets.

[30]  M. Moasser.  Targeting the function of the HER2 oncogene in human cancer therapeutics , 2007, Oncogene.

[31]  I. Kostova.  Ruthenium complexes as anticancer agents. , 2006, Current medicinal chemistry.

[32]  R. Mass.  The HER receptor family: a rich target for therapeutic development. , 2004, International journal of radiation oncology, biology, physics.

[33]  J. Baselga.  Why the epidermal growth factor receptor? The rationale for cancer therapy. , 2002, The oncologist.

[34]  L. Nilsson,et al.  Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K , 2001 .

[35]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .